Advances in pancreatic cancer biomarkers
Biomarkers play an essential role in the management of patients with invasive cancers. Pancreatic ductal adenocarcinoma (PDC) associated with poor prognosis due to advanced presentation and limited therapeutic options. This is further complicated by absence of validated screening and predictive biom...
Saved in:
Main Authors: | Syed Hasan (Author), Rojymon Jacob (Author), Upender Manne (Author), Ravi Paluri (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic options for ampullary carcinomas. A review
by: Dileep Kumar Reddy Regalla, et al.
Published: (2019) -
Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
by: Ravi K. Paluri, et al.
Published: (2019) -
Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
by: Xin Qiu, et al.
Published: (2023) -
Advances in Pancreatic Cancer
Published: (2018) -
microRNA based prognostic biomarkers in pancreatic Cancer
by: Shixiang Guo, et al.
Published: (2018)